Introduction
normality test and a Wilcox rank sum test using R software Version 3.5.0. The concentration of total immunoglobulin E (IgE) was determined using sandwich ELISA (Genesis Diagnostics Ltd). The ELISA was performed in duplicate using the 1 3 3
recommended protocol, and absorbance was measured at 450nm using an ELX800 Shapiro-Wilk normality test and an unpaired T test using R software Version 3.5.0. Quantitative analysis of endotoxin concentration
Circulating bacterial endotoxin concentration was measured using a Pierce Scientific). The assay was performed in triplicate using the recommended protocol,
and absorbance was measured at 450nm using an ELX800 Absorbance reader test and an unpaired T test using R software Version 3.5.0. Total RNA was extracted from 500µl of human plasma using the Qiagen serum and 1 4 7 plasma miRNeasy kit. The quantity and quality of the RNA extracts was determined Interestingly, there were numerous genes that were expressed in a condition specific was comprised of Asthma_1, Asthma_3, Asthma_5, Control_1, Asthma_4, and
Control_3. The dominance of asthmatic subjects in Cluster 2 suggests the possibility
of a distinct asthma mRNA profile that would likely be more apparent in a larger Control_1 and Control_3. This asthmatic subject was the youngest member of the 3 7 3 asthma cohort, with an age of 19 years, and the subject had been suffering from
asthma for just 14 years compared to the mean length of 38 years that our other
subjects had been living with the disease. It is tempting to speculate that asthmatic
mRNA profiles become more divergent from control profiles as the disease
progresses over time, however our sample size restricts further analysis of this.
The diversity of genes being expressed within the circulatory system was assessed
using principal coordinate analysis (PCA) (Figure 3 ). per Million mapped (FPKM) reads that had been normalised using log2. Only genes 3 8 8
with mean FPKM scores > 6.0 were included in the dataset, and the principal 3 8 9
coordinate analysis was performed using Bray Curtis dissimilarity and R software. Blue data points = Control; Orange datasets = Asthma
Examination of Bray Curtis dissimilarity between the subjects found that,
unsurprisingly, samples clustered similarly to that observed using unsupervised
clustering (Euclidean distance). PCA analysis, did however reveal that the control 3 9 9
and asthmatic subjects were differentiated on the basis of principal component (PC)
2, whereby asthmatic subjects had a positive PC2 score and control subjects had a 4 0 1 negative PC2 score. Moreover, Asthma_4 clustered with the control subjects, thus 4 0 2 providing additional evidence that this subject has a mRNA profile similar to the 4 0 3 control subjects. To determine whether differential gene expression could be linked to asthma 4 0 6 pathology, we compared the differentially expressed genes identified herein, to a 4 0 7
recently released database of genes associated with asthma pathology -AllerGAtlas, in the asthmatic subjects, 8 genes were identified in the asthma gene database.
These genes included complement regulatory protein 46 (CD46), interleukin 7 Materials, S4). The genes identified in the asthma gene database (41) were found to influence a cell activity in the asthmatic subjects. Approximately 10,000,000 micro RNA (miRNA) reads were generated from each and there were no significant differences in read count identified between the control
and asthma samples. studies (66-70). To determine whether the asthmatic subjects had distinct miRNA other control subjects.
Of interest, the two asthma sub-clusters that formed appeared to be governed by the clustered together and both subjects were free of additional atopic complication,
whereas Asthma_1 and Asthma_2 clustered together, and both subjects had
additional atopic complications such as allergic rhinitis. As we have noted previously,
further study using a larger asthma cohort would be required to determine this
association given the clear heterogeneity noted.
Statistical analysis revealed that 13 miRNAs were differentially expressed (defined
as FDR P value < 0.05 and a fold change > 2.0) in the asthmatic subjects compared
to the control subjects ( Figure 5 , see also Supplementary Materials S5). As Of interest, with regards to atopic asthma pathology, was the predicted activated notion is further supported by the prediction of significant inhibition of the upstream
regulator SOX4 in the asthmatic cohort. This transcription factor has been observed 5 3 8
to suppress Th2 differentiation (72), and thus its inhibition would allow expansion of 5 3 9
the Th2 populations within the asthmatic subjects. The predicted activated state of
GFI1 would also influence innate immune responses within the asthmatic cohort.
The transcription factor has been found to have a role in the development and found to be involved in allergic lung inflammation (74-76).
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However, it should be noted causal inference analysis was performed on mRNA Causal inference analysis using IPA was also used to predict the downstream primarily assessed by examination of the predicted canonical pathways and bio-
functions impacted. Fourteen canonical pathways were found to have significantly altered biological 5 5 9 activity (P < 0.05) within the asthmatic subjects (Table 6 ). In line with the findings of existence of similar / shared underlying immune pathologies in the three diseases. activity in the asthmatic subjects (n = 4) compared to the control subjects (n = gene expression are genes that had significantly increased numbers of mRNA reads
in the asthma plasma samples, and molecules with decreased gene expression are
genes that had significantly decreased numbers of mRNA reads in the asthma
plasma samples. Canonical pathways that are defined as being significantly altered
in the asthma subjects have a P value < 0.05. With regards to biological functions likely to be impacted by changes in the observed were predicted to have altered activity within the asthmatic cohort (Table 7) .
Altered activity was defined as having a P value < 0.05 and a Z score > 2.0 or < -2.0;
and in total 10 biological functions had significantly altered activity within the 5 8 7
asthmatic subjects ( Table 7) . the asthmatic subjects (n = 4) compared to the control subjects (n = 5). Casual
inference using Ingenuity Pathway Analysis (IPA) software was used to predict 5 9 2 biological functions likely to have altered activity in the asthmatic subjects. This was
determined through analysis of genes and miRNA that had altered expression in the 5 9 4 asthmatic subjects, to predict which biological functions would likely be altered.
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Biological functions predicted to be significantly altered in the asthmatic subjects
were defined as having a P value < 0.05 and a Z score greater than 2.0. Biological
functions with predicted increased activity were defined as having a Z score > 2.0,
and biological functions with predicted decreased activity were defined as having a Z 80.3%), the Actinobacteria phylum (Total relative abundance = 7.5%, Control mean 6 2 9 = 6.0%, Asthma mean = 7.5%), and the Firmicutes phylum (Total relative abundance 6 3 0 = 6.6%, Control mean = 3.0%, Asthma mean = 9.0%) (Figure 6 ). Please refer to (38)
for a detailed appraisal of our experimental controls. 16S rRNA gene from bacterial DNA isolated from plasma samples from control 6 3 8 subjects (n = 5) and asthmatic subjects (n = 5). The generated bacterial sequences 6 3 9
were clustered (99% identity) in Operational Taxonomic Units (OTUs) to the Silva In the asthmatic samples, 16S amplification and sequencing revealed a significant 6 4 5 increase in Firmicutes (P value = 0.0148), associated with a concomitant decrease in
Proteobacteria (P value = 0.0702) (Figure 6 ). To a lesser extent, members of the
Bacteroidetes phylum were also detected in the blood samples, with increased levels Analysis of the diversity of RNA expression within the blood revealed that our 8 0 1
asthmatic donors had more similar RNA profiles to one another than they did to the 8 0 2 control subjects; this was particularly apparent in the miRNA analysis. When biomarkers, we identified various mRNAs in the circulation that were expressed in a
condition-specific manner, including HIST1H3C, PRAM1, RAB6B and CD93. Of
these, elevated levels of soluble CD93 have been previously reported in the serum
of asthmatics during acute asthma exacerbations (101) and in the serum of steroid-
naïve asthmatic patients (102). Our microbial characterisation informed by 16S rRNA amplification and sequencing,
revealed increased levels of Firmicutes and decreased levels of Proteobacteria
within the blood of our asthmatic donors. This finding was accompanied by increased
bacterial diversity within the blood of asthmatic subjects, and the identification of several additional bacterial taxa displaying significantly altered levels dependent on asthmatic state is thought to be indicative of reduced Proteobacteria carriage within
the asthmatic subjects at a distant microbiome niche (e.g. the gut, airways and oral
cavity). This may explain the decreased levels of endotoxin (protein) detected in our
asthmatic subjects, given that endotoxin-producing gram-negative bacteria dominate
this phylum. Previous studies have associated childhood asthma and reduced
endotoxin exposure, and it is interesting to note that we detected this same
phenomenon in our adult asthma cohort, many years following childhood.
Furthermore, our asthma patients were found to have increased levels of 8 2 9
Bacteroidetes rRNA, and this appeared to be dependent on medication status with
those patients taking anti-inflammatory medications having lower levels of circulating
Bacteroidetes 16S rRNA than those who were not. As blood circulates the body and
functions as a medium that samples from virtually all body sites (103), it was not 8 3 3
possible to determine herein the microbial niche from which these signals originated.
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That said, we hypothesise that changes in the blood are reflective of dysbiosis at 8 3 5 distant site(s) with well-characterised microbial communities (e.g. the gut, oral cavity
and skin), and have significant biomarker potential. This study provides a valuable insight into the systemic changes evident in the HDM-
associated asthma, identifies a range of molecules that are present in the circulation
in a condition-specific manner (with clear biomarker potential), and highlights a range of hypotheses for further study. Moreover, our data also provide an insight into the investigated, and will be of use for informing sample size calculations for future studies. This research was part funded by the National Institute for Health Research Health expressed are those of the author(s) and not necessarily those of the NHS, the
NIHR, the Department of Health or Public Health England. other interests that might be perceived to influence the results and/or discussion reported in 8 6 6 this paper. DPT, MOL and TWG conceived the original study. DPT developed and refined the molecular 8 7 0 approach used. EW conducted the laboratory work. EW and DPT conducted the data 8 7 1
analysis. EW and DPT interpreted the original data. EW and DPT prepared the original 8 7 2 manuscript. EW, MOL, TWG and DPT reviewed and approved the manuscript. Increased CD127 expression on activated FOXP3 1 CD4 1 regulatory T cells. 48. Kelly EAB, Koziol-White CJ, Clay KJ, Liu LY, Bates ME, Bertics PJ, et al. HJ. Neurotensin stimulates exocytotic histamine secretion from rat mast cells 
